Natixis’s Amgen AMGN Stock Holding History

Natixis’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,500	Closed	-$9.24M	–	990
2024 Q1	$9.24M	Buy	+32,500	New	+$9.51M	0.05%	244
2022 Q3	–	Sell	-738	Closed	-$180K	–	1076
2022 Q2	$180K	Buy	+738	New	+$181K	﹤0.01%	1038

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Natixis's AMGN Position: Q2 2026 in Review

Natixis reduced its Amgen (AMGN) stake by 81% in Q2 2026, selling an estimated $4.98M and leaving 3,343 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Natixis first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $230M in Q3 2019. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Natixis held 3,343 shares of Amgen worth $1.21M as of Q2 2026.
Natixis sold 14,542 Amgen shares in Q2 2026, an estimated $4.98M.
Amgen made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #706 holding.
Natixis first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
Natixis's Amgen position peaked at $230M in Q3 2019.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.